TNDM
Tandem Diabetes Care, Inc.
Medical Devices · Healthcare · United States
19.79
close · 2026-10-29
value
23
cheaper than peers23
quality
14
stronger fundamentals14
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 1.52× | 74 |
| price to book | 10.55× | 15 |
| forward P/E | 124.50× | 8 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | -5.4% | 50 |
| revenue growth | 5.8% | 44 |
| return on equity | -48.0% | 31 |
| debt to equity | 567.0% | 5 |
4 of 4 measures available
Facts
| market cap | $1B |
| free cash flow | -$43.9M |
| employees | 2,500 |
| first trade | 2013-11-14 |
| next earnings | 2026-11-05 |
| fundamentals updated | 2026-08-10 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -3.04 | -1.47 | -3.43 | -1.47 |
| free cash flow | -$108.3M | $5.0M | -$128.1M | $16.4M |
| net income | -$204.7M | -$96.0M | -$222.6M | -$94.6M |
| revenue | $1.01B | $940.2M | $747.7M | $801.2M |
| unusual items | -$20.0M | -$1.3M | $0 | $147,000 |